Sunshine Guojian Reports Strong Q3 Growth and Advances Key R&D Programs
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (SHA: 688336), a China-based company, released its 2025 third-quarter...
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (SHA: 688336), a China-based company, released its 2025 third-quarter...
China-based Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, (SHA: 688336) a subsidiary of 3SBio Inc. (HKG:...
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, (SHA: 688336) a subsidiary of 3SBio Inc. (HKG: 1530),...
China-based Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA: 688336) has announced that it has received...
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA: 688336), a subsidiary of 3SBio Inc. (HKG: 1530),...
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, (SHA: 688336) a subsidiary of 3SBio Inc. (HKG: 1530),...